- Home
- PFLT vs SNN Comparison
PFLT vs SNN Comparison
Compare PFLT & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFLT
- SNN
- Stock Information
- Founded
- PFLT 2010
- SNN 1856
- Country
- PFLT United States
- SNN United Kingdom
- Employees
- PFLT N/A
- SNN N/A
- Industry
- PFLT Finance: Consumer Services
- SNN Industrial Specialties
- Sector
- PFLT Finance
- SNN Health Care
- Exchange
- PFLT Nasdaq
- SNN Nasdaq
- Market Cap
- PFLT 1.0B
- SNN 13.2B
- IPO Year
- PFLT N/A
- SNN 1999
- Fundamental
- Price
- PFLT $10.75
- SNN $30.28
- Analyst Decision
- PFLT Buy
- SNN Hold
- Analyst Count
- PFLT 6
- SNN 3
- Target Price
- PFLT $11.17
- SNN $27.50
- AVG Volume (30 Days)
- PFLT 780.5K
- SNN 1.2M
- Earning Date
- PFLT 08-11-2025
- SNN 07-31-2025
- Dividend Yield
- PFLT 11.45%
- SNN 2.37%
- EPS Growth
- PFLT N/A
- SNN 56.15
- EPS
- PFLT 0.86
- SNN 0.47
- Revenue
- PFLT $232,975,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- PFLT $45.52
- SNN $6.87
- Revenue Next Year
- PFLT $8.87
- SNN $5.19
- P/E Ratio
- PFLT $12.46
- SNN $33.29
- Revenue Growth
- PFLT 49.56
- SNN 4.70
- 52 Week Low
- PFLT $8.82
- SNN $23.69
- 52 Week High
- PFLT $12.02
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- PFLT 67.58
- SNN 54.96
- Support Level
- PFLT $10.44
- SNN $29.50
- Resistance Level
- PFLT $10.59
- SNN $31.43
- Average True Range (ATR)
- PFLT 0.14
- SNN 0.42
- MACD
- PFLT 0.04
- SNN 0.02
- Stochastic Oscillator
- PFLT 93.55
- SNN 56.27
About PFLT PennantPark Floating Rate Capital Ltd.
PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generate revenue in the form of interest income on the debt securities and dividends.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.